AIM
Forgot password?

Bio Nano Consulting signs agreement with The School of Pharmacy, University of London and clinches first Phase 1 cancer drug formulation contract

02 August 2010

Bio Nano Consulting (BNC), specialists in bio and nanotechnology partnerships between the academic and industrial sectors, has announced the signing of a service level agreement (SLA) with The School of Pharmacy, University of London.

BNC has already utilised the new arrangement to secure a contract with an undisclosed US-based biotechnology company. Under the terms of the agreement, BNC will manage a specific project, carried out by scientists at the School of Pharmacy, to formulate a phase I cancer drug with the goal of making the treatment orally available, rather than delivered intravenously. The four month proof of concept project is intended to demonstrate dissolution and oral availability and, once successful, will progress to a second project stage with School scientists working closely with the biotechnology company to take the formulation through to late-stage development. Undisclosed licensing and milestone terms have been agreed between the School and the client, subject to formulation success.

Read the full story here

« all news